Public real-world data decision thresholds for hybrid vascular control in complex robot-assisted partial nephrectomy

PURPOSE: Hybrid endovascular balloon occlusion has been described during complex robot-assisted partial nephrectomy (RAPN), but no reproducible public-data phenotype or access-risk-adjusted threshold has been validated. The selected public evidence was audited, and a hypothesis was formulated for future testing. METHODS: A public-data quantitative evidence synthesis was combined with a conceptual decision model. ​Six selected reports of hybrid partial nephrectomy were rechecked. Possible patient overlap and incomplete reporting meant that the reported procedures could not be treated as a cohort of independent patients. A 20-patient branch-occlusion study provided a numerical illustration using Jeffreys-prior beta-binomial models and an additive expected-loss equation. KiTS23, C4KC-KiTS, TCGA-KIRC and MAUDE were mapped for possible future research; their individual patient or event records were not analysed.​ RESULTS: The illustrative cohort reported no conversion, one escalation from branch to main-artery balloon occlusion and one minor puncture-site bruise. The posterior median conversion probability was 1.1% (95% credible interval [CrI] < 0.1-11.7%). For each outcome with one reported event, the posterior median probability was 5.8% (95% CrI 0.5-21.1%). The median loss-equivalence boundary increased from 8.2% to 37.4% when the hypothetical access-harm weight increased from one to six. These values are not clinical thresholds. No anatomical model was trained or validated. CONCLUSION: Hybrid vascular control in complex RAPN is best framed as a hypothesis for future testing, not as a patient-selection rule. Prospective outcome-labelled data and comparative clinical evaluation are required before performance, safety or utility can be assessed.

Authors

Institutions

Publication Details

Journal
World Journal of Urology
Published
2026-11-18
DOI
https://doi.org/10.1007/s00345-026-06938-5
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Public real-world data decision thresholds for hybrid vascular control in complex robot-assisted partial nephrectomy

Rafał B. Drobot
4 links
World Journal of Urology
Renal cell carcinoma treatment
article

Public real-world data decision thresholds for hybrid vascular control in complex robot-assisted partial nephrectomy

Rafał B. Drobot
article en

Abstract

PURPOSE: Hybrid endovascular balloon occlusion has been described during complex robot-assisted partial nephrectomy (RAPN), but no reproducible public-data phenotype or access-risk-adjusted threshold has been validated. The selected public evidence was audited, and a hypothesis was formulated for future testing. METHODS: A public-data quantitative evidence synthesis was combined with a conceptual decision model. ​Six selected reports of hybrid partial nephrectomy were rechecked. Possible patient overlap and incomplete reporting meant that the reported procedures could not be treated as a cohort of independent patients. A 20-patient branch-occlusion study provided a numerical illustration using Jeffreys-prior beta-binomial models and an additive expected-loss equation. KiTS23, C4KC-KiTS, TCGA-KIRC and MAUDE were mapped for possible future research; their individual patient or event records were not analysed.​ RESULTS: The illustrative cohort reported no conversion, one escalation from branch to main-artery balloon occlusion and one minor puncture-site bruise. The posterior median conversion probability was 1.1% (95% credible interval [CrI] < 0.1-11.7%). For each outcome with one reported event, the posterior median probability was 5.8% (95% CrI 0.5-21.1%). The median loss-equivalence boundary increased from 8.2% to 37.4% when the hypothetical access-harm weight increased from one to six. These values are not clinical thresholds. No anatomical model was trained or validated. CONCLUSION: Hybrid vascular control in complex RAPN is best framed as a hypothesis for future testing, not as a patient-selection rule. Prospective outcome-labelled data and comparative clinical evaluation are required before performance, safety or utility can be assessed.

World Journal of UrologyVol. 44(1)
European Association of Urology (NL), Międzyleski Szpital Specjalistyczny w Warszawie (PL), Cardinal Stefan Wyszynski University in Warsaw (PL)
Good health and well-being
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon